CAR-T Immunotherapy

Biotech Blogs

World Lupus Day 2025: Emerging Pipeline Advances from Biopharma
Biotech News

Poseida Joins Roche in $1.5B Deal to Deliver Next-Gen CAR-T Therapies

Developing Predictive Cancer Models and More Persistent CAR T-cell Therapies through Enhanced Metabolic Fitness

December 11, 2024
Biotech Blogs

The Challenges and Promise of CAR T-Cell Therapy in Oncology

Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations

October 29, 2024

Exploring Applications of CAR-T Therapy Outside Oncology: Strategies for Applying Lessons Learned

June 19, 2024

Adoptive Cell Therapy: Exploring and Influencing Heterogeneity of TILs and CAR T Cells

May 02, 2024

Development of CAR-T Cells for T-ALL Targeting CCR9

March 06, 2024

4th Generation Lentiviral Vectors: An Improved Gene Delivery System

October 02, 2023
Blogs

Developing More Affordable Cellular Immunotherapies: Interview with CytoMed Therapeutics — Xtalks Life Science Podcast Ep. 117

CAR T-Cell Therapies: Extending Hope with Broadened Access

March 23, 2023

A Tumor Microenvironment-Based Multiomics Analysis for Predictive Modelling

December 09, 2022

The Added Value of Flow Cytometry in CAR T-Cell Clinical Trials

May 31, 2022
Biotech News

Novartis’ CAR-T Therapy Kymriah Could Be Manufactured by French CDMO Cell for Cure
Biotech News

Novartis’ CAR-T Therapy Kymriah Secures Second FDA Approval in Lymphoma
Biotech News

CAR-T and CRISPR Come Together for Better Cancer Immunotherapy